RECIST 1.1 Criteria Predict Recurrence-Free Survival in Advanced Ovarian Cancer Submitted to Neoadjuvant Chemotherapy
European Journal of Obstetrics & Gynecology and Reproductive Biology(2019)
Key words
Ovarian cancer,Neoadjuvant chemotherapy,Interval debulking surgery,RECIST,Response
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined